Literature DB >> 24423162

Albendazole-induced associated acute hepatitis and bicytopenia.

Nadia Ben Fredj1, Amel Chaabane, Zohra Chadly, Najeh Ben Fadhel, Naceur A Boughattas, Karim Aouam.   

Abstract

Acute hepatitis induced by albendazole is rarely reported. We describe herein an original case of acute hepatitis associated with bicytopenia after albendazole intake. This paper is the first to describe a possible association of a hematologic disorder and acute hepatitis, both induced by albendazole therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24423162     DOI: 10.3109/00365548.2013.835068

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Case Report: Analytically Confirmed Severe Albenzadole Overdose Presenting with Alopecia and Pancytopenia.

Authors:  Morgan A A Riggan; Gabriel Perreault; Anita Wen; Veronica Raco; Susi Vassallo; Roy Gerona; Robert S Hoffman
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

2.  Fatal pancytopenia due to albendazole treatment for strongyloidiasis.

Authors:  Fanfan Xing; Haiyan Ye; Jin Yang; Jasper Fuk-Woo Chan; Wai-Kay Seto; Pearl Ming-Chu Pai; Kwok-Yung Yuen; Derek Ling-Lung Hung
Journal:  IDCases       Date:  2018-04-04

3.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.